Clinical trials
Image clinical trials
Below are recruiting image clinical trials, each written for real people, not researchers. We’re tracking 2,159 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06659705RecruitingPhase 2
New PET scan for early pancreatic cancer detection
This trial tests a new type of PET scan that uses a special tracer (FAPI) to get clearer images of pancreatic cancer. The goal is to find cancer earlier and better plan surgery or treatment.
Saint-CloudAges 18 years+ - NCT06666881Recruiting
Exercise training for head and neck cancer patients
This trial studies if exercise training can improve outcomes for people with head and neck squamous cell cancer who need chemotherapy and radiation. It uses body scans to see if muscle changes from exercise are linked to better prognosis.
New Taipei CityAges 20–80 - NCT06663891Recruiting
MRI study of anergic depression in older adults
This study uses MRI brain scans to look for differences between people whose anergic depression started before age 60 and those whose depression began later in life (after 60). It aims to help understand the root causes of this specific type of depression in older adults.
Strasbourg, Grand EstAges 60–90 - NCT06658782Recruiting
MRI vs ultrasound for liver cancer detection in high-risk people
This trial compares two types of scans to see which detects liver cancer better in people at high risk. You would receive either an MRI with contrast or an ultrasound every 6 months to monitor for liver cancer.
Oxford, OxonAges 18 years+ - NCT06514235Recruiting
Brachytherapy for vaginal cancer
This study is testing a special type of internal radiation (called image-guided brachytherapy) for women with vaginal cancer. It aims to give high doses directly to the tumor while limiting side effects to nearby organs.
Rotterdam, South HollandAges 18 years+ - NCT06649812RecruitingPhase 2
Testing a combination targeted therapy (ViPOR) for aggressive B-cell lymphoma
This trial tests a new combination of targeted drugs called ViPOR for people with aggressive B-cell lymphoma that has come back or not responded to previous treatment. The goal is to see if this treatment can help when standard therapies haven't worked.
Tucson, ArizonaAges 18 years+ - NCT06654037RecruitingPhase 1
Testing abemaciclib plus 5-FU for advanced colorectal cancer
This trial is testing whether adding a targeted drug called abemaciclib to the standard chemotherapy 5-FU can help people with a specific type of advanced colorectal cancer (MSS) that has stopped responding to other treatments. The goal is to see if this combination is safe and effective.
Irvine, CaliforniaAges 18 years+ - NCT06645808RecruitingEarly Phase 1
PET imaging study for various solid tumors
This study uses a special PET scan to see if a new imaging agent can help find and monitor certain solid tumors. It is for people with colon, rectal, sarcoma, breast, lung, head and neck, esophageal, stomach, pancreas, bladder cancers, or glioblastoma who have had standard treatment before surgery.
Groningen, Provincie GroningenAges 18 years+ - NCT06649071Enrolling by invitation
Obesity classification and brain imaging study
This study looks at how obesity is classified and what brain imaging can show in people with obesity. It may help researchers understand different types of obesity and how they affect the brain.
Nanjing, JiangsuAges 20–65 - NCT06650033Recruiting
Pelvic adaptive radiotherapy study
This trial tests a special type of radiation called adaptive radiotherapy for people with certain pelvic cancers. Adaptive radiotherapy adjusts the treatment plan each day based on changes in your body, which may help target the cancer more precisely and reduce side effects.
St Leonards, New South WalesAges 18 years+ - NCT06648642Recruiting
MRI-guided brain stimulation for alcohol use disorder
This study tests whether a new type of brain stimulation, guided by MRI and a robot, can help reduce heavy drinking in people with alcohol use disorder. The treatment is non-invasive and aims to improve brain function related to cravings.
San Antonio, TexasAges 18–65 - NCT06648577Recruiting
3D ultrasound heart muscle wave measurements
This study uses 3D ultrasound to measure mechanical waves in the heart muscle of people with different severities of mitral regurgitation (a leaky heart valve). It aims to better understand how the heart adapts to the leak, which could help guide treatment decisions.
Paris, ParisAges 18 years+ - NCT06652763Recruiting
MRI scan for heart failure with normal pumping strength
This study uses a special MRI scan with a natural contrast agent (manganese) to look at how well the heart muscle works in people with heart failure who still have normal pumping strength. The goal is to learn more about why this type of heart failure happens.
LeicesterAges 18 years+ - NCT06652399Enrolling by invitation
Heart imaging study for children with myocarditis
This trial uses special heart imaging tests (MRI or CT scans) to look at the hearts of children with myocarditis, a condition where the heart muscle is inflamed. The goal is to better understand the inflammation and help guide treatment.
Chengdu, SichuanAges 1–18 - NCT06317181Recruiting
Liver disease evaluation with AI-enhanced ultrasound
This trial tests whether a new deep-learning computer program can better detect liver disease using ultrasound data. It may help improve diagnosis without extra procedures.
DresdenAges 18 years+ - NCT06644196Recruiting
Building an eye image database with new laser technology
This study uses a special laser to take detailed images of the eye. It aims to create a database that could help doctors better understand and diagnose eye conditions like glaucoma, macular degeneration, and retinal diseases.
ParisAges 18 years+ - NCT06639828RecruitingPhase 4
Safety study of Sonazoid for liver ultrasound in children
This trial tests a contrast agent called Sonazoid, which is used during an ultrasound to get clearer pictures of the liver. It is for children and teens who have one or more spots in the liver that need to be checked. The goal is to see if Sonazoid is safe and works well for children.
MünchenAges Up to 18 years - NCT06641817Enrolling by invitation
Heart imaging study for Kawasaki disease
This study uses heart imaging to better understand Kawasaki disease. It may help doctors assess heart health in affected children and teenagers.
Chengdu, SichuanAges Up to 18 years - NCT06636734RecruitingPhase 2
Lovastatin plus pembrolizumab for advanced head and neck cancer
This trial tests whether adding lovastatin (a cholesterol-lowering drug) to pembrolizumab (an immunotherapy) works better than pembrolizumab alone for head and neck cancer that has come back or spread. It's for people who haven't had immunotherapy before and aren't already on a statin.
Atlanta, GeorgiaAges 18 years+ - NCT06634628RecruitingEarly Phase 1
Testing a new brain scan tracer for Huntington's disease
This trial tests a new radioactive tracer called [11C]CHDI-00491009 that may show mutant huntingtin protein in the brain using a PET scan. It aims to find out if the tracer is safe and helps see Huntington's disease changes. If you have early-stage Huntington's or are a healthy volunteer, you may be able to join.
LeuvenAges 18–64 - NCT06632977RecruitingPhase 2
Matching targeted treatments to your prostate cancer's genetics
This trial is testing whether matching your cancer's specific genetic changes to a targeted treatment can help control metastatic prostate cancer that has stopped responding to standard hormone therapy and chemotherapy. You may receive a drug, a radioactive treatment, or a combination based on your tumor's molecular profile.
Birmingham, AlabamaAges 18 years+ - NCT06639074RecruitingPhase 2
Folate receptor dendritic cell vaccine for ovarian cancer
This trial tests a personalized vaccine made from your own immune cells, designed to target a protein called folate receptor alpha found on many ovarian cancer cells. It is for people who have finished initial chemotherapy and have no signs of cancer remaining, to try to prevent it from coming back.
Scottsdale, ArizonaAges 18 years+ - NCT06629896Recruiting
Comparing contrast mammogram vs MRI for high-risk breast cancer surveillance
This trial compares two advanced imaging methods—contrast-enhanced mammography and MRI—to see which is better for detecting breast cancer early in women at high risk. If you are at high risk and have not had breast cancer before, this study could help guide your future screening.
Reggio Emilia, Italy/Reggio EmiliaAges 35–60 - NCT06625034RecruitingPhase 3
Comparing two radiation planning methods for prostate cancer
This trial tests two ways to plan radiation treatment for prostate cancer: one using a computer program (RapidPlan) and the other using human experts. The goal is to see if the computer-assisted method works as well or better.
Scottsdale, ArizonaAges 18 years+
Hear when a new Image trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for image?
- Yes. Clin2 currently lists 2,159 recruiting image studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a image trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a image trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.